Why McKinsey’s $650m settlement marks a turning point in the opioid epidemic
McKinsey & Company has agreed to pay $650 million under a deferred prosecution agreement with the United States Department of Justice (DOJ), resolving allegations tied ... Read More
FDA approval for Zurnai Auto-Injector: A new weapon in the fight against opioid overdose
In a major development in the battle against the opioid epidemic, Purdue Pharma’s Zurnai Auto-Injector has been granted approval by the US Food and Drug ... Read More